TRIM33 and dermatomyositis: In contrast with some other forms of DM, such as anti-TIF1γ (anti-transcription intermediary factor 1-gamma) DM, anti-MDA5 DM does not seem to be significantly associated with an increased risk of cancer (3, 4, 7, 9, 10).